Sleep Apnea Devices Market Size and Share Analysis by Type (Therapeutic Devices, Diagnostic Devices), End User (Sleep Laboratories, At-Home) - Global Industry Revenue Estimation and Demand Forecast to 2030

Market Overview

The sleep apnea devices market size stood at $7,687.3 million in 2022, and it is expected to grow at a CAGR of 7.2% during 2022–2030, to reach $13,386.5 million by 2030.

This can be attributed to the surging incidence of obstructive sleep apnea (OSA), unhealthy lifestyles of people, changes in sleep and diet patterns, and immense work pressure. Additionally, the rise in the number of geriatric and obese people leads to the increase in the incidence of chronic insomnia. In addition, the escalating count of depression, chronic illness, and anxiety patients is resulting in the surging demand for sleep apnea devices. Moreover, the development of such devices would help in tapping the high insomnia burden areas in developing nations.

In the coming years, it is predicted that the adoption of such gadgets will significantly increase in APAC. This can be ascribed to the rising OSA prevalence, intense job pressure, and poor lifestyles. The demand in the APAC region is also being driven by the growing elderly population.

Rising Use of Portable Devices

With the evolution of technologically advanced products, there has been a rise in the adoption of portable devices. For instance, products with additional features, such as the use of an algorithm and pressure sensor to determine the best pressure, are available in the market.

Moreover, portable devices are compact and easy to take anywhere, which further adds to the demand for these products. Furthermore, the growing usage of oral appliances is also supporting the market growth, since these devices are comparatively economical. It has been observed that developed and developing countries are struggling with increasing healthcare costs per capita, which propel the demand for low-cost therapeutic devices.

In addition, oral appliances are less expensive in comparison to continuous positive airway pressure (CPAP) devices and other surgical procedures required to treat the condition, thereby leading to high demand for such products among the general population. Thus, the rising adoption of oral appliances and portable devices is boosting the growth of the market.

Therapeutic Devices Holds Larger Share in the Market

Therapeutic devices hold larger share in the market. The global market is marked by the availability of various therapeutic devices for the treatment of sleep apnea in which sleeping aids are the supporting products for the treatment. It is also anticipated to be the faster growing category in the global market, advancing at a CAGR of around 9% during the forecast period. This growth is mainly expected to be led by the increasing number of OSA cases, across the globe.

PAP devices accounted around 35% share in the global sleep apnea therapeutic devices market, in 2022. These devices are the most commonly prescribed treatment option by the doctors due to its targeted and effective medication benefits over other sleep apnea devices. However, oral appliances devices is expected to be the fastest growing category in the global market, demonstrating a CAGR around 10% during the forecast period.

North America Led Global Market

Globally, North America led the market for sleep apnea devices, with around 45% share in 2022. This can be credited to the snowballing incidence of sleeping disorders. Furthermore, the rise in the occurrence of various health conditions, such as obesity and heart diseases, which are high-risk factors for sleep apnea is also expected to contribute toward the growth of the market.

Moreover, several government bodies are running awareness programs to educate people and medical practitioners about healthy sleeping habits. Moreover, the key players in the market are investing huge capital to develop technologically efficient, effective, and easy-to-use devices.

It has been observed that changes in lifestyle patterns often lead to many sleeping disorders. Moreover, the increasing consumption of tobacco, caffeine, and alcohol also affects the sleep cycle of an individual. Furthermore, the growth in the number of sleep care centers in the region is expected to boost the growth of the market.

Moreover, it is expected to advance at a CAGR of around 5% throughout the projection period, in the region. As North America marks the presence of several centers, such as Carilion Clinic, Adam Moscovitch, Florida Lung, Asthma and Sleep Specialists, Oregon Sleep Associates, and Sound Sleep Health, will further drive the growth in the region.

Increasing Government Support for Start-Up Companies

Sleeping disorders and comorbid diseases are rising at a rapid pace in developing nations, which has led to increasing investments by government and private organizations in research and development, to provide better treatment options to patients in these countries.

Moreover, governments in developing and developed countries are supporting various start-ups, which are working on the control and prevention of sleep-related disorders. These start-ups are focusing on providing tailored technologies, in terms of monitoring devices, apps, and therapies to patients across the globe.

Growing Healthcare Facilities

Globally, the funding in the healthcare sector to control sleep-related disorders, such as insomnia and apnea, is increasing. Thus, manufacturers are also investing in the development of healthcare facilities to control sleep-related disorders. For instance, the Philips APAC Center in Singapore, the regional headquarters of Royal Philips, has opened the first sleep and respiratory education center in Southeast Asia, according to a March 2018 announcement.

In this new facility, Philips would work with international sleep and respiratory physicians and partners, such as Singapore Health Services (SingHealth), to train healthcare professionals across the region for better diagnosis and treatment of related disorders.

Thus, various initiatives and funding by government and private firms for the treatment of sleep-related disorders are key factors driving the market demand.

Explore more about this report - Request free sample

Increasing Geriatric Population

The increasing geriatric population is also playing a major role in driving the growth of the global market. With aging, people suffer from health problems, due to psychological factors and changes in cardiac rhythm, thus making them more susceptible to sleep disorders. Moreover, insomnia and OSA are some of the most common sleeping disorders observed in aged people. In order to improve the quality of life and ensure a healthy lifestyle among the geriatric population, the demand for such devices is growing rapidly.

According to the population division of the Department of Economic and Social Affairs (DESA) in the United Nations Secretariat, aged people are expected to make up 30% of the population in China by 2050. The population of people aged 60 years and above is expected to reach 3.1 billion by 2100, globally.

Fastest Growing Region Was APAC

Globally, APAC was the fastest growing region during the historical period. This is owing to the growing prevalence of OSA and changes in diet and lifestyle patterns. According to a study funded by the JurongHealth Services Research and Quality Improvement Grant, one in three Singaporeans have moderate-to-severe OSA and up to one in 10 Singaporeans suffer from severe apnea. The study also found that the Chinese and Malays observed high rates of OSA in comparison to Indians.

Furthermore, the region is also witnessing a significant rise in unhealthy lifestyle patterns among the younger population, such as staying up late and interrupting sleep due to work pressure. Moreover, the growing elderly population in the region is more susceptible to apnea, due to multiple comorbid diseases, which will drive the demand for therapeutic and diagnostic devices.

Additionally, the growing number of undiagnosed apnea patients or those who face delayed diagnosis, due to the lack of awareness in the region is a health concern. The Neurology and Sleep Centre undertook a campaign to spread awareness about the harmful effects of sleep disorders within India. All these factors are propelling the growth of the market in the APAC region, which is predicted to be the fastest-growing market, witnessing a CAGR of around 8%, during the projection period.

Top Sleep Apnea Devices Manufacturers Are:

• Koninklijke Philips N.V.
• DeVilbiss Healthcare GmbH
• ResMed Inc.
• Fisher & Paykel Healthcare Limited
• Löwenstein Medical Technology GmbH & Co. KG
• BMC Medical Co. Ltd.
• Compumedics Limited
• SomnoMed Limited
• BRAEBON Medical Corporation
• Natus Medical Incorporated

Market Size Breakdown by Segment

The report analyzes the impact of the major drivers and restraints on the market, to offer accurate market estimations for 2017–2030.

Based on Type

• Therapeutic Devices
  • Positive airway pressure (PAP) devices
    • Continuous positive air pressure (CPAP) devices
    • Automatic positive air pressure (APAP) devices
    • Bi-level positive air pressure (BPAP) devices
  • Facial interfaces
    • Masks
    • Cushions
  • Oral appliances
  • Adaptive servo-ventilators (ASVs)
• Diagnostic Devices
  • Polysomnography devices
  • Respiratory polygraphs
  • Pulse oximeters
  • Actigraphy devices
  • Sleep screening devices
  • Home sleep testing devices

Based on End User

• Sleep Laboratories
• At-Home

Geographical Analysis

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
• Asia-Pacific
  • Japan
  • China
  • Australia
  • India
• Latin America
  • Brazil
  • Mexico
• Middle East and Africa
  • Saudi Arabia
  • U.A.E.
  • South Africa